H-FABP presence equals increased risk

McCann CJ et al7

• Elevated H-FABP is a significant predictor of death or MI within 1 year7
• H-FABP provides additional prognostic information independent of Troponin T, ECG and clinical examination7

Increased H-FABP concentrations confers increased risk

Viswanathan K et al10

• "Patients with H-FABP concentrations >6.48 µg/L had significantly increased risk of adverse events"10
• "Among Troponin negative patients, the cut-off of 6.48 µg/L identified patients at very high risk of adverse outcomes independent of patient age and serum Creatinine" 10

H-FABP predicts mortality after ACS

Kilcullen N et al5

• Raised concentrations of H-FABP are strongly predictive of mortality after ACS5
• H-FABP allows identification of high risk patients across the full range of Troponin concentrations5
• A negative test result for both Troponin I and H-FABP was associated with 0% mortality at 6 months5
  

H-FABP prognostic value across the ACS spectrum

Kilcullen N et al5

• "This demonstrated the additive value of H-FABP, particularly for ACS subtypes such as Unstable Angina, traditionally considered to be associated with low long-term risk"5